Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Altschuller Susan

SEC-identified person · CIK 1817988 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Eliem Therapeutics, Inc. ELYM Chief Financial Officer filed 2025–2026
Mural Oncology plc MURA US Director filed 2023–2024
Cerevel Therapeutics Holdings, Inc. CERF Chief Financial Officer filed 2023–2024
Immunogen, Inc. IMGN SVP and CFO filed 2020–2022

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.